MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/nop/npaf128

Медицинская библиотека · Neuro-oncology practice · 2025

The role of neurosurgery for brain metastases between 2012 and 2022: Results of the multicenter SUBAROMA study.

Jünger Stephanie T, Karadachi Hanah Hadice, Sure Ulrich, Ahmadipour Yahya, Häni Levin, Nasiri Danial, Araceli Tommaso, Proescholdt Martin, Schmidt Nils Ole, Cattaneo Andrea, Nickl Vera, Scheichel Florian, Marhold Franz, Grau Stefan J, Hamisch Christina A, Ricklefs Franz L, Zghaibeh Yahya, Nogova Lucia, Kocher Martin, Goldbrunner Roland H

СтатьяПеревод в очереди

Аннотация

BACKGROUND

We analyzed the role of neurosurgery combined with postoperative treatment according to current guidelines in a real-world cohort of patients with brain metastasis (BM) over an 11-year period to (re-)evaluate predictors of local intracranial recurrence (LR) and overall survival (OS).

METHODS

We conducted the SUBARoMA study (Surgery for brain metastases: a retrospective multicenter analysis), including patients undergoing surgery as initial treatment for their BM. Significant factors impacting LR and OS were analyzed by univariate (Kaplan-Meier) and multivariate (Cox regression) methods.

RESULTS

We included 2,751 patients. Resection significantly improved patients' postoperative Karnofsky Performance Score (KPS, P < .001). Gross-total resection (rate 73%) increased by fluorescence guidance but exerted no effect on morbidity (rate 20.4%) (P < .001, respectively). The risk of LR was 23.5% at 1 year and 40.4% at 4 years. Postoperative systemic- (P = .021) and radiotherapy (P < .001) had an independent impact on LR. Mean/median OS was 15.0/7.5 months. The strongest independent predictors of OS were age, number of BM, active extracranial tumor, as well as improvement of postoperative KPS, radiation-, and systemic therapy including targeted and/or immunotherapy (P < .001, respectively). Over the 11-year period, application of whole-brain radiotherapy decreased in favor of focal radiation, and administration of systemic treatment, particularly targeted and/or immunotherapies, increased. By combining surgery, postoperative radiation, and systemic therapy, 5-year survival rates of >30% were achieved.

CONCLUSION

The SUBARoMA study confirms the crucial role of neurosurgery for patients with BM by improving their KPS to enable guideline-conforming postoperative treatment and underscores meticulous patient selection for surgical management of BM.

Для цитирования: Jünger Stephanie T, Karadachi Hanah Hadice, Sure Ulrich, Ahmadipour Yahya, Häni Levin, Nasiri Danial, Araceli Tommaso, Proescholdt Martin, Schmidt Nils Ole, Cattaneo Andrea, Nickl Vera, Scheichel Florian, Marhold Franz, Grau Stefan J, Hamisch Christina A, Ricklefs Franz L, Zghaibeh Yahya, Nogova Lucia, Kocher Martin, Goldbrunner Roland H. The role of neurosurgery for brain metastases between 2012 and 2022: Results of the multicenter SUBAROMA study.. Neuro-oncology practice. 2025. DOI: 10.1093/nop/npaf128.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.